{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-075008","form_type":"8-K","ticker":"ONCO","cik":"0001782107","company_name":"Onconetix, Inc.","filed_at":"2024-09-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.502562+00:00","generated_at":"2026-05-31T06:39:45.559398+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Onconetix faces Nasdaq delisting risk; must meet initial listing criteria including $4.00 minimum bid price","bullets":["Nasdaq ruled Proteomedix AG acquisition triggers Change of Control; must satisfy initial listing rules including $4.00 minimum bid price.","Company has until Sept 16, 2024 to regain Bid Price Rule compliance ($1.00 close for 10 days); extension for stockholders' equity runs to Nov 4, 2024.","Board proposes reverse stock split (1-for-30 to 1-for-60) to boost per-share price and meet Nasdaq minimum price and equity requirements.","Failure to comply could lead to delisting; common stock would trade OTC, materially reducing liquidity and capital access."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-075008","json":"https://secwatch.observer/filing/0001213900-24-075008.json","markdown":"https://secwatch.observer/filing/0001213900-24-075008.md","text":"https://secwatch.observer/filing/0001213900-24-075008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782107/000121390024075008/0001213900-24-075008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782107/000121390024075008/ea0213181-8k_onconetix.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:39:45.559398+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}